Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israele, Tel Aviv-Giaffa
Strauss Ido
27 anni di esperienza
Clinica certificata da :
| Israele | Turchia | Austria | |
| Coltello Gamma | da $13,800 | da $6,300 | da $32,000 |
Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.
He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.
Il medico è specializzato in neuro-oncologia e ha una vasta esperienza nel trattamento di tumori cerebrali complessi. Con un focus su metodi di trattamento innovativi, il medico ha contribuito significativamente ai progressi nella cura dei pazienti in questo campo impegnativo. Il medico è riconosciuto per la sua leadership nella neuro-oncologia e per l'impegno nel migliorare i risultati dei pazienti attraverso la ricerca e l'eccellenza clinica.<\/p>
Il medico offre una gamma completa di procedure neurochirurgiche, tra cui craniotomia, resezione transnasale di tumori, escissione di tumori della base cranica e ipofisectomia trans-sfenoidale. Ulteriore esperienza include interventi chirurgici per idrocefalo, interventi di derivazione, rimozione chirurgica di cisti cerebrali, chirurgia della siringomielia, riparazione di aneurismi cerebrali e embolizzazione di tumori cerebrali.<\/p>
Riconosciuto per i significativi contributi alla neurochirurgia, il medico ha numerose pubblicazioni e partecipa attivamente a conferenze. Il medico è membro di diverse organizzazioni prestigiose, tra cui l'Associazione Europea di Neurochirurgia e la Società Internazionale di Neurochirurgia Pediatrica.<\/p>
Il medico è un neurochirurgo di spicco in Israele, a capo del Dipartimento di Neurochirurgia presso il Centro Medico Ichilov (Sourasky). Dopo aver conseguito una laurea in medicina presso l'Università Ben-Gurion del Negev, il medico ha completato un tirocinio nel trattamento chirurgico avanzato delle malattie della base del cranio negli Stati Uniti.<\/p>
Specializzato nel trattamento dei tumori cerebrali sia negli adulti che nei bambini, il medico impiega tecniche endoscopiche minimamente invasive per i tumori del cranio, facilitando un recupero più rapido del paziente. Il medico ha eseguito con successo circa 70 interventi di meningioma e oltre 100 interventi di tumori della base del cranio.<\/p>
Israeli neurosurgeons treat cavernoma using advanced microsurgical resection and non-invasive Gamma Knife radiosurgery. Specialized clinics utilize intraoperative MRI navigation and neuro-navigation to ensure precision. High-volume centers like Sourasky Medical Center and Assuta Medical Center provide comprehensive care for both adults and children.
Bookimed Expert Insight: While public institutions like Sourasky perform over 34,000 operations yearly, patients often choose private facilities like Assuta for specific technology access. Assuta performs over 92,000 operations annually and offers shorter wait times for Gamma Knife procedures. This high surgical volume is a key indicator of procedural safety across Israeli neurosurgical departments.
Patient Consensus: Patients note it's important to get an MRI with SWI sequences for accurate bleed history before surgery. Many recommend seeking a second opinion from surgeons like Dr. Margalit Navo who specialize in complex skull base cases.
Expert neurosurgeons in Israel confirm cavernoma bleeding and treatment necessity through high-field 3-Tesla MRI and detailed localized symptom mapping. Doctors use susceptibility-weighted imaging to detect hemosiderin rings. They follow the two-bleed rule for deep-seated lesions to balance surgical risk against neurological safety.
Bookimed Expert Insight: Israeli neurosurgery departments prioritize 3-Tesla MRI over standard scans because they reveal popcorn-shaped hemosiderin deposits. These deposits are the only definitive markers of past bleeding. Data from centers like Sourasky Medical Center show that intraoperative MRI technology is standard for complex cases. This allows surgeons to verify the removal of blood-stained margins in real-time, reducing the risk of seizure recurrence.
Patient Consensus: Patients emphasize that standard MRI scans often miss micro-bleeds. Many recommend requesting susceptibility-weighted imaging specifically to ensure a correct diagnosis when symptoms first appear.
Israeli specialists locate cavernomas with millimeter precision using advanced neuro-navigation and 3D imaging systems. Medical centers achieve diagnostic accuracy up to 99% for these pathologies. Surgeons map lesions relative to eloquent brain areas to ensure maximum safety during complex neurosurgical procedures.
Bookimed Expert Insight: Israeli neurosurgery departments like Sourasky Medical Center integrate intraoperative MRI with image-guided resection. This is vital because brain tissue shifts once the skull is opened. Real-time imaging ensures the 99% diagnostic accuracy translates into surgical precision, even if the cavernoma moves slightly during the procedure.
Patient Consensus: Patients note that combining fMRI with tractography helps them feel more confident about surgery near language centers. Many emphasize that intraoperative mapping confirmed their lesion was safer to remove than initial scans suggested.
Recognized neurosurgical experts for cavernoma care in Israel include Prof. Margalit Navo, Prof. Zvi Cohen, and Dr. Roth Jonathan. These specialists operate at JCI-accredited institutions like Sourasky Medical Center and Sheba Medical Center. They employ advanced techniques such as Gamma Knife and microsurgery for vascular pathologies.
Bookimed Expert Insight: Sourasky Medical Center stands out for its sheer scale, performing 34,000 operations annually. While Sheba is known for clinical research, Sourasky holds a 90% success rate for complex oncology and vascular cases. This high volume often translates to more consistent outcomes for rare vascular malformations like cavernomas.
Patient Consensus: Patients emphasize the need for strong neuroradiology support alongside a surgeon. Many seek multiple consultations because surgical plans for cavernomas can vary significantly between different specialists.
Patients treating cavernomas in Israel can expect high success rates. Superficial cavernomas show over 90% favorable long-term outcomes through microsurgery. Specialists often achieve 85% seizure-free results after five years. Advanced techniques like Gamma Knife radiosurgery successfully prevent rebleeding in approximately 70% to 85% of cases.
Bookimed Expert Insight: Data shows Israeli centers like Sourasky Medical Center manage massive patient volumes with over 34,000 annual operations. This high frequency creates a significant expertise gap. For example, Dr. Margalit Navo has performed over 100 skull base procedures. This volume-based mastery is why these centers report a 90% average success rate in complex neurological treatments.
Patient Consensus: Patients emphasize getting multiple neurosurgeon opinions on resectability for lesions in eloquent areas. Many note that while surgery offers a permanent cure, post-operative rehabilitation is vital for managing subtle memory or sensory issues.
Screening and genetic testing are recommended if a relative has multiple lesions or a known hereditary mutation. Hereditary cerebral cavernous malformations (CCM) account for 10% to 20% of cases. Israeli neurosurgeons typically initiate screening with a brain MRI for all first-degree biological relatives.
Bookimed Expert Insight: Data suggests specialized clinics in Israel like Sourasky Medical Center (Ichilov) or Sheba Medical Center are preferred for these cases. These centers house dedicated brain tumor banks and neuro-oncology units led by experts like Dr. Zvi Cohen. While sporadic cases rarely need genetics, these clinics frequently find multiple lesions in relatives that would be missed without high-resolution intraoperative MRI or specialized digital imaging. Starting with a consultation with a head neurosurgeon, like Professor Margalit Navo, ensures the screening is medically justified and focused on high-risk family members.
Patient Consensus: Patients note it's important to document mutations clearly to simplify their relatives' future care. Many emphasize starting with non-invasive imaging like an MRI to find asymptomatic spots before proceeding to genetic tests.
Awake craniotomy is chosen when lesions like cavernomas reside in eloquent brain regions. These areas control movement, speech, or vision. Keeping patients conscious allows real-time functional mapping. This technique minimizes the risk of permanent neurological deficits. It is the gold standard for high-precision resection.
Bookimed Expert Insight: Israeli neurosurgical centers like Sourasky Medical Center (Ichilov) leverage massive surgical volumes—performing over 34,000 operations annually—to refine awake protocols. Experienced surgeons like Dr. Zvi Cohen at Sheba integrate intraoperative MRI with awake mapping. This dual-monitoring approach is a conclusion drawn from their high success in complex neuro-oncology. Choosing a center with specialized brain tumor banks often indicates more advanced intraoperative research and safer outcomes.
Patient Consensus: Patients note that the experience feels similar to dental work with local anesthesia rather than major surgery. Many emphasize that confirming if a lesion is in an eloquent area during the first consultation is vital.